We are live on
!
Find out more
N
Natixis Portfolio holdings
AUM
$28B
1-Year Est. Return
26.79%
Natixis is a global financial services business line of Groupe BPCE, offering a range of services including corporate and investment banking, asset management, insurance, and wealth management, with a focus on green and sustainable finance.
This Fund
S&P 500
This Quarter
Est. Return
-2.18%
1 Year Est. Return
+26.79%
3 Year Est. Return
+97.72%
5 Year Est. Return
+108.83%
10 Year Est. Return
+452.99%
AUM
$13.1B
AUM Growth
+$754M
(+6.1%)
Cap. Flow
+$1.16B
Cap. Flow
% of AUM
8.89%
Top 10 Holdings %
Top 10 Hldgs %
38.02%
Holding
1,188
New
182
Increased
340
Reduced
340
Closed
221
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$379M |
| 2 |
NVIDIA
NVDA
|
+$323M |
| 3 |
Amazon
AMZN
|
+$133M |
| 4 |
UnitedHealth
UNH
|
+$97.5M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$86.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$89.2M |
| 2 |
ExxonMobil
XOM
|
+$83.6M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$83.1M |
| 4 |
CVS Health
CVS
|
+$82.2M |
| 5 |
Eli Lilly
LLY
|
+$66.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.23% |
| 2 | Healthcare | 11.42% |
| 3 | Energy | 7.9% |
| 4 | Consumer Discretionary | 6.67% |
| 5 | Financials | 5.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Ally Financial
ALLY
$13.1B
| $90.2K | ﹤0.01% |
3,382
-133,537
| -98% | -$3.73M |
|
777
WEC Energy
WEC
$37.7B
| $89.7K | ﹤0.01% |
1,113
-9,250
| -89% | -$804K |
|
778
Webster Financial
WBS
$12.3B
| $88K | ﹤0.01% |
2,183
+1,719
| +370% | +$73.1K |
|
779
East-West Bancorp
EWBC
$17.9B
| $85.8K | ﹤0.01% |
1,627
-7
| -0.4% | -$394 |
|
780
West Fraser Timber
WFG
$5.18B
| $80K | ﹤0.01% |
1,100
-8
| -0.7% | -$629 |
|
781
Bath & Body Works
BBWI
$4.01B
| $80K | ﹤0.01% |
2,366
-44,361
| -95% | -$1.61M |
|
782
Axsome Therapeutics
AXSM
$12.4B
| $80K | ﹤0.01% |
+1,144
| New | +$85.5K |
|
783
QuantumScape Corp
QS
$3B
| $79.6K | ﹤0.01% |
11,894
+4,673
| +65% | +$38K |
|
784
Herc Holdings
HRI
$5.43B
| $79.5K | ﹤0.01% |
668
-3
| -0.4% | -$391 |
|
785
Columbus McKinnon
CMCO
$465M
| $79.1K | ﹤0.01% |
2,265
-10
| -0.4% | -$381 |
|
|
ITCI
786
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $77K | ﹤0.01% |
1,478
-14,403
| -91% | -$839K |
|
787
Rio Tinto
RIO
$148B
| $76.6K | ﹤0.01% |
+1,203
| New | +$76.7K |
|
788
Watts Water Technologies
WTS
$11.5B
| $72.1K | ﹤0.01% |
417
-6
| -1% | -$1.1K |
|
789
Greystone Housing Impact Investors LP
GHI
$121M
| $67K | ﹤0.01% |
4,373
| – | – |
|
790
Franklin Electric
FELE
$4.67B
| $66.7K | ﹤0.01% |
748
-8
| -1% | -$774 |
|
791
Nutrien
NTR
$32.7B
| $66.1K | ﹤0.01% |
1,069
-150
| -12% | -$9.49K |
|
792
VF Corp
VFC
$6.68B
| $64.7K | ﹤0.01% |
3,664
+2,611
| +248% | +$49.7K |
|
793
Lucid Motors
LCID
$2.46B
| $64.2K | ﹤0.01% |
1,149
-781
| -40% | -$50.6K |
|
794
Caterpillar
CAT
$409B
| $60.9K | ﹤0.01% |
+223
| New | +$60.5K |
|
795
Vale
VALE
$62.9B
| $60.1K | ﹤0.01% |
4,485
-18
| -0.4% | -$245 |
|
796
Westlake Corp
WLK
$9.46B
| $59.6K | ﹤0.01% |
478
+376
| +369% | +$48.3K |
|
797
Kymera Therapeutics
KYMR
$9.1B
| $58.1K | ﹤0.01% |
+4,180
| New | +$84K |
|
798
Toro Company
TTC
$8.93B
| $57.7K | ﹤0.01% |
694
-76,686
| -99% | -$7.39M |
|
|
BCYC
799
Bicycle Therapeutics
BCYC
$270M
| $55.1K | ﹤0.01% |
2,768
-7
| -0.3% | -$160 |
|
800
American States Water
AWR
$3.39B
| $54.4K | ﹤0.01% |
692
-7
| -1% | -$596 |
|
Similar funds
TWC
FDCDDQ
PCH
NA
Natixis's Q3 2023 Portfolio in Review
As of Q3 2023, Natixis held 1,188 positions worth $13.1B, up 6.1% from $12.3B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Natixis deployed $1.16B of net new capital in Q3 2023, opening 182 new positions and adding to 340 existing holdings. Its largest new stake was Oneok: 965,015 shares worth $61.2M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 21% a quarter earlier, followed by Healthcare and Energy.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $89.2M trimmed.
- Natixis's largest Q3 2023 buy was Oneok: 965,015 shares worth $61.2M.
- Natixis added most to Apple in Q3 2023, an estimated $379M increase.
- Natixis's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $89.2M.
- Natixis fully exited Bristol-Myers Squibb in Q3 2023, selling an estimated $83.1M.
- Natixis's ten largest holdings make up 38% of its $13.1B portfolio in Q3 2023.
- Natixis opened 182 new positions and closed 221 in Q3 2023.
- Natixis's portfolio value rose 6.1% quarter-over-quarter to $13.1B.
Based on Natixis's 13F filing for Q3 2023, filed 14 Nov 2023.